From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans Octarine Bio will soon bring its biosynthesized psilocybin into human clinical trials through a new partnership with Clerkenwell Health, a London-based research firm that specializes in psychedelic medicines.